nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—Crohn's disease	0.421	1	CbGaD
Estropipate—Exemestane—Prednisone—Crohn's disease	0.414	1	CrCrCtD
Estropipate—Exacerbation of asthma—Mesalazine—Crohn's disease	0.00432	0.0282	CcSEcCtD
Estropipate—Polyp—Mercaptopurine—Crohn's disease	0.00342	0.0223	CcSEcCtD
Estropipate—Cyst—Mercaptopurine—Crohn's disease	0.00311	0.0203	CcSEcCtD
Estropipate—Glucose tolerance decreased—Prednisone—Crohn's disease	0.00297	0.0194	CcSEcCtD
Estropipate—Rash generalised—Mesalazine—Crohn's disease	0.00265	0.0173	CcSEcCtD
Estropipate—Erythema nodosum—Mesalazine—Crohn's disease	0.00261	0.017	CcSEcCtD
Estropipate—Abdominal bloating—Mesalazine—Crohn's disease	0.00237	0.0154	CcSEcCtD
Estropipate—Vaginal moniliasis—Mesalazine—Crohn's disease	0.00224	0.0146	CcSEcCtD
Estropipate—Glucose tolerance impaired—Prednisone—Crohn's disease	0.00222	0.0144	CcSEcCtD
Estropipate—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.00215	0.014	CcSEcCtD
Estropipate—Vulvovaginal mycotic infection—Mesalazine—Crohn's disease	0.00206	0.0134	CcSEcCtD
Estropipate—Polyp—Azathioprine—Crohn's disease	0.00204	0.0133	CcSEcCtD
Estropipate—Hirsutism—Mesalazine—Crohn's disease	0.00194	0.0126	CcSEcCtD
Estropipate—Neoplasm—Mercaptopurine—Crohn's disease	0.00188	0.0122	CcSEcCtD
Estropipate—Thromboembolism—Prednisone—Crohn's disease	0.00188	0.0122	CcSEcCtD
Estropipate—Cyst—Azathioprine—Crohn's disease	0.00185	0.0121	CcSEcCtD
Estropipate—Abdominal cramps—Mesalazine—Crohn's disease	0.00167	0.0109	CcSEcCtD
Estropipate—Thrombosis—Mesalazine—Crohn's disease	0.00159	0.0104	CcSEcCtD
Estropipate—Metrorrhagia—Mesalazine—Crohn's disease	0.00158	0.0103	CcSEcCtD
Estropipate—Epilepsy—Prednisone—Crohn's disease	0.00157	0.0102	CcSEcCtD
Estropipate—Blister—Mesalazine—Crohn's disease	0.00157	0.0102	CcSEcCtD
Estropipate—Dementia—Prednisone—Crohn's disease	0.00145	0.00948	CcSEcCtD
Estropipate—Neoplasm malignant—Azathioprine—Crohn's disease	0.00145	0.00945	CcSEcCtD
Estropipate—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00141	0.00918	CcSEcCtD
Estropipate—Breast disorder—Mercaptopurine—Crohn's disease	0.00136	0.00888	CcSEcCtD
Estropipate—Tenderness—Mesalazine—Crohn's disease	0.00129	0.00842	CcSEcCtD
Estropipate—Breast pain—Mesalazine—Crohn's disease	0.00129	0.00842	CcSEcCtD
Estropipate—Amenorrhoea—Mesalazine—Crohn's disease	0.00128	0.00836	CcSEcCtD
Estropipate—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00128	0.00836	CcSEcCtD
Estropipate—Pancreatitis—Mercaptopurine—Crohn's disease	0.00128	0.00833	CcSEcCtD
Estropipate—Bone disorder—Mesalazine—Crohn's disease	0.00125	0.00814	CcSEcCtD
Estropipate—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00124	0.00808	CcSEcCtD
Estropipate—Hypocalcaemia—Mesalazine—Crohn's disease	0.00123	0.00803	CcSEcCtD
Estropipate—Cough increased—Mesalazine—Crohn's disease	0.00123	0.00803	CcSEcCtD
Estropipate—Embolism venous—Prednisone—Crohn's disease	0.00118	0.0077	CcSEcCtD
Estropipate—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00114	0.00744	CcSEcCtD
Estropipate—Hypernatraemia—Prednisone—Crohn's disease	0.00114	0.00739	CcSEcCtD
Estropipate—Vaginal inflammation—Mesalazine—Crohn's disease	0.00113	0.00735	CcSEcCtD
Estropipate—Neoplasm—Azathioprine—Crohn's disease	0.00112	0.00729	CcSEcCtD
Estropipate—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.00112	0.102	CbGpPWpGaD
Estropipate—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.00112	0.102	CbGpPWpGaD
Estropipate—Cystitis noninfective—Mesalazine—Crohn's disease	0.0011	0.00718	CcSEcCtD
Estropipate—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0011	0.00716	CcSEcCtD
Estropipate—Cystitis—Mesalazine—Crohn's disease	0.00109	0.0071	CcSEcCtD
Estropipate—Vaginal infection—Mesalazine—Crohn's disease	0.00106	0.00694	CcSEcCtD
Estropipate—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00104	0.00675	CcSEcCtD
Estropipate—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00103	0.0067	CcSEcCtD
Estropipate—Hirsutism—Prednisone—Crohn's disease	0.00103	0.00669	CcSEcCtD
Estropipate—Bladder pain—Mesalazine—Crohn's disease	0.00102	0.00664	CcSEcCtD
Estropipate—Hypertonia—Mesalazine—Crohn's disease	0.000989	0.00644	CcSEcCtD
Estropipate—Optic neuritis—Prednisone—Crohn's disease	0.00097	0.00632	CcSEcCtD
Estropipate—Immune system disorder—Mercaptopurine—Crohn's disease	0.000943	0.00614	CcSEcCtD
Estropipate—Embolism—Prednisone—Crohn's disease	0.00093	0.00606	CcSEcCtD
Estropipate—Alopecia—Mercaptopurine—Crohn's disease	0.000922	0.00601	CcSEcCtD
Estropipate—Malnutrition—Mercaptopurine—Crohn's disease	0.000909	0.00592	CcSEcCtD
Estropipate—Dermatitis bullous—Mesalazine—Crohn's disease	0.000857	0.00558	CcSEcCtD
Estropipate—Migraine—Mesalazine—Crohn's disease	0.000806	0.00525	CcSEcCtD
Estropipate—Neuritis—Prednisone—Crohn's disease	0.000799	0.00521	CcSEcCtD
Estropipate—Mood swings—Mesalazine—Crohn's disease	0.000776	0.00505	CcSEcCtD
Estropipate—Arthralgia—Mercaptopurine—Crohn's disease	0.000774	0.00504	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000768	0.005	CcSEcCtD
Estropipate—Pancreatitis—Azathioprine—Crohn's disease	0.000762	0.00496	CcSEcCtD
Estropipate—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000757	0.0689	CbGpPWpGaD
Estropipate—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000757	0.0689	CbGpPWpGaD
Estropipate—Abdominal discomfort—Azathioprine—Crohn's disease	0.000745	0.00485	CcSEcCtD
Estropipate—Oedema—Mercaptopurine—Crohn's disease	0.000742	0.00483	CcSEcCtD
Estropipate—Breast disorder—Mesalazine—Crohn's disease	0.00074	0.00482	CcSEcCtD
Estropipate—Cramp muscle—Mesalazine—Crohn's disease	0.000737	0.0048	CcSEcCtD
Estropipate—Skin disorder—Mercaptopurine—Crohn's disease	0.00072	0.00469	CcSEcCtD
Estropipate—Abdominal distension—Mesalazine—Crohn's disease	0.000712	0.00464	CcSEcCtD
Estropipate—Asthma—Mesalazine—Crohn's disease	0.000708	0.00461	CcSEcCtD
Estropipate—Influenza—Mesalazine—Crohn's disease	0.000708	0.00461	CcSEcCtD
Estropipate—Pancreatitis—Mesalazine—Crohn's disease	0.000694	0.00452	CcSEcCtD
Estropipate—Infestation NOS—Azathioprine—Crohn's disease	0.000693	0.00451	CcSEcCtD
Estropipate—Infestation—Azathioprine—Crohn's disease	0.000693	0.00451	CcSEcCtD
Estropipate—Amenorrhoea—Prednisone—Crohn's disease	0.000679	0.00442	CcSEcCtD
Estropipate—Abdominal discomfort—Mesalazine—Crohn's disease	0.000678	0.00442	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000676	0.0044	CcSEcCtD
Estropipate—Dysuria—Mesalazine—Crohn's disease	0.000662	0.00431	CcSEcCtD
Estropipate—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000658	0.00428	CcSEcCtD
Estropipate—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000655	0.00427	CcSEcCtD
Estropipate—Weight increased—Mesalazine—Crohn's disease	0.000644	0.0042	CcSEcCtD
Estropipate—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00064	0.00417	CcSEcCtD
Estropipate—Infestation—Mesalazine—Crohn's disease	0.000631	0.00411	CcSEcCtD
Estropipate—Infestation NOS—Mesalazine—Crohn's disease	0.000631	0.00411	CcSEcCtD
Estropipate—Depression—Mesalazine—Crohn's disease	0.000629	0.0041	CcSEcCtD
Estropipate—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000619	0.00403	CcSEcCtD
Estropipate—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000597	0.00389	CcSEcCtD
Estropipate—Sinusitis—Mesalazine—Crohn's disease	0.000592	0.00386	CcSEcCtD
Estropipate—Erythema multiforme—Azathioprine—Crohn's disease	0.000588	0.00383	CcSEcCtD
Estropipate—Body temperature increased—Mercaptopurine—Crohn's disease	0.000586	0.00382	CcSEcCtD
Estropipate—Rhinitis—Mesalazine—Crohn's disease	0.000568	0.0037	CcSEcCtD
Estropipate—Fluid retention—Prednisone—Crohn's disease	0.000567	0.00369	CcSEcCtD
Estropipate—Pharyngitis—Mesalazine—Crohn's disease	0.000562	0.00366	CcSEcCtD
Estropipate—Immune system disorder—Azathioprine—Crohn's disease	0.000562	0.00366	CcSEcCtD
Estropipate—Mediastinal disorder—Azathioprine—Crohn's disease	0.00056	0.00365	CcSEcCtD
Estropipate—Oedema peripheral—Mesalazine—Crohn's disease	0.000558	0.00364	CcSEcCtD
Estropipate—Alopecia—Azathioprine—Crohn's disease	0.00055	0.00358	CcSEcCtD
Estropipate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000546	0.00356	CcSEcCtD
Estropipate—Erythema multiforme—Mesalazine—Crohn's disease	0.000536	0.00349	CcSEcCtD
Estropipate—Eye disorder—Mesalazine—Crohn's disease	0.000529	0.00345	CcSEcCtD
Estropipate—Cardiac disorder—Mesalazine—Crohn's disease	0.000526	0.00342	CcSEcCtD
Estropipate—Angiopathy—Mesalazine—Crohn's disease	0.000514	0.00335	CcSEcCtD
Estropipate—Immune system disorder—Mesalazine—Crohn's disease	0.000512	0.00333	CcSEcCtD
Estropipate—Mediastinal disorder—Mesalazine—Crohn's disease	0.000511	0.00333	CcSEcCtD
Estropipate—Diarrhoea—Mercaptopurine—Crohn's disease	0.000507	0.0033	CcSEcCtD
Estropipate—Alopecia—Mesalazine—Crohn's disease	0.000501	0.00326	CcSEcCtD
Estropipate—Thrombophlebitis—Prednisone—Crohn's disease	0.0005	0.00326	CcSEcCtD
Estropipate—Mental disorder—Mesalazine—Crohn's disease	0.000496	0.00323	CcSEcCtD
Estropipate—Erythema—Mesalazine—Crohn's disease	0.000493	0.00321	CcSEcCtD
Estropipate—Flatulence—Mesalazine—Crohn's disease	0.000486	0.00317	CcSEcCtD
Estropipate—Tension—Mesalazine—Crohn's disease	0.000484	0.00315	CcSEcCtD
Estropipate—Nervousness—Mesalazine—Crohn's disease	0.000479	0.00312	CcSEcCtD
Estropipate—Back pain—Mesalazine—Crohn's disease	0.000477	0.00311	CcSEcCtD
Estropipate—Muscle spasms—Mesalazine—Crohn's disease	0.000474	0.00309	CcSEcCtD
Estropipate—Vomiting—Mercaptopurine—Crohn's disease	0.000471	0.00307	CcSEcCtD
Estropipate—Injury—Prednisone—Crohn's disease	0.000471	0.00307	CcSEcCtD
Estropipate—Rash—Mercaptopurine—Crohn's disease	0.000468	0.00305	CcSEcCtD
Estropipate—Dermatitis—Mercaptopurine—Crohn's disease	0.000467	0.00304	CcSEcCtD
Estropipate—Myalgia—Azathioprine—Crohn's disease	0.000461	0.003	CcSEcCtD
Estropipate—Arthralgia—Azathioprine—Crohn's disease	0.000461	0.003	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000458	0.00298	CcSEcCtD
Estropipate—Angioedema—Mesalazine—Crohn's disease	0.000451	0.00294	CcSEcCtD
Estropipate—Purpura—Prednisone—Crohn's disease	0.000449	0.00293	CcSEcCtD
Estropipate—Vertigo—Mesalazine—Crohn's disease	0.000443	0.00289	CcSEcCtD
Estropipate—Nausea—Mercaptopurine—Crohn's disease	0.00044	0.00287	CcSEcCtD
Estropipate—Infection—Azathioprine—Crohn's disease	0.000439	0.00286	CcSEcCtD
Estropipate—Palpitations—Mesalazine—Crohn's disease	0.000436	0.00284	CcSEcCtD
Estropipate—Cough—Mesalazine—Crohn's disease	0.00043	0.0028	CcSEcCtD
Estropipate—Skin disorder—Azathioprine—Crohn's disease	0.000429	0.0028	CcSEcCtD
Estropipate—Arthralgia—Mesalazine—Crohn's disease	0.00042	0.00273	CcSEcCtD
Estropipate—Myalgia—Mesalazine—Crohn's disease	0.00042	0.00273	CcSEcCtD
Estropipate—Anxiety—Mesalazine—Crohn's disease	0.000418	0.00273	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000417	0.00272	CcSEcCtD
Estropipate—Irritability—Prednisone—Crohn's disease	0.000414	0.00269	CcSEcCtD
Estropipate—Mood swings—Prednisone—Crohn's disease	0.00041	0.00267	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000403	0.00262	CcSEcCtD
Estropipate—Oedema—Mesalazine—Crohn's disease	0.000402	0.00262	CcSEcCtD
Estropipate—Anaphylactic shock—Mesalazine—Crohn's disease	0.000402	0.00262	CcSEcCtD
Estropipate—Infection—Mesalazine—Crohn's disease	0.0004	0.0026	CcSEcCtD
Estropipate—Nervous system disorder—Mesalazine—Crohn's disease	0.000395	0.00257	CcSEcCtD
Estropipate—Skin disorder—Mesalazine—Crohn's disease	0.000391	0.00255	CcSEcCtD
Estropipate—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000381	0.00248	CcSEcCtD
Estropipate—Abdominal distension—Prednisone—Crohn's disease	0.000377	0.00246	CcSEcCtD
Estropipate—Pancreatitis—Prednisone—Crohn's disease	0.000367	0.00239	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000367	0.00239	CcSEcCtD
Estropipate—Insomnia—Mesalazine—Crohn's disease	0.000364	0.00237	CcSEcCtD
Estropipate—Paraesthesia—Mesalazine—Crohn's disease	0.000361	0.00235	CcSEcCtD
Estropipate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000361	0.00235	CcSEcCtD
Estropipate—Somnolence—Mesalazine—Crohn's disease	0.000358	0.00233	CcSEcCtD
Estropipate—Dyspepsia—Mesalazine—Crohn's disease	0.000354	0.00231	CcSEcCtD
Estropipate—Abdominal pain—Azathioprine—Crohn's disease	0.000349	0.00228	CcSEcCtD
Estropipate—Body temperature increased—Azathioprine—Crohn's disease	0.000349	0.00228	CcSEcCtD
Estropipate—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000347	0.00226	CcSEcCtD
Estropipate—Fatigue—Mesalazine—Crohn's disease	0.000347	0.00226	CcSEcCtD
Estropipate—Pain—Mesalazine—Crohn's disease	0.000344	0.00224	CcSEcCtD
Estropipate—Constipation—Mesalazine—Crohn's disease	0.000344	0.00224	CcSEcCtD
Estropipate—Weight increased—Prednisone—Crohn's disease	0.000341	0.00222	CcSEcCtD
Estropipate—Hyperglycaemia—Prednisone—Crohn's disease	0.000338	0.0022	CcSEcCtD
Estropipate—Depression—Prednisone—Crohn's disease	0.000333	0.00217	CcSEcCtD
Estropipate—Acute coronary syndrome—Prednisone—Crohn's disease	0.000329	0.00214	CcSEcCtD
Estropipate—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000329	0.00214	CcSEcCtD
Estropipate—Myocardial infarction—Prednisone—Crohn's disease	0.000327	0.00213	CcSEcCtD
Estropipate—Neuropathy peripheral—Prednisone—Crohn's disease	0.000327	0.00213	CcSEcCtD
Estropipate—Hypersensitivity—Azathioprine—Crohn's disease	0.000326	0.00212	CcSEcCtD
Estropipate—Urticaria—Mesalazine—Crohn's disease	0.00032	0.00208	CcSEcCtD
Estropipate—Abdominal pain—Mesalazine—Crohn's disease	0.000318	0.00207	CcSEcCtD
Estropipate—Body temperature increased—Mesalazine—Crohn's disease	0.000318	0.00207	CcSEcCtD
Estropipate—Diarrhoea—Azathioprine—Crohn's disease	0.000302	0.00197	CcSEcCtD
Estropipate—Hypersensitivity—Mesalazine—Crohn's disease	0.000297	0.00193	CcSEcCtD
Estropipate—Dizziness—Azathioprine—Crohn's disease	0.000292	0.0019	CcSEcCtD
Estropipate—Asthenia—Mesalazine—Crohn's disease	0.000289	0.00188	CcSEcCtD
Estropipate—Pruritus—Mesalazine—Crohn's disease	0.000285	0.00185	CcSEcCtD
Estropipate—Vomiting—Azathioprine—Crohn's disease	0.000281	0.00183	CcSEcCtD
Estropipate—Eye disorder—Prednisone—Crohn's disease	0.00028	0.00182	CcSEcCtD
Estropipate—Rash—Azathioprine—Crohn's disease	0.000279	0.00181	CcSEcCtD
Estropipate—Dermatitis—Azathioprine—Crohn's disease	0.000278	0.00181	CcSEcCtD
Estropipate—Headache—Azathioprine—Crohn's disease	0.000277	0.0018	CcSEcCtD
Estropipate—Diarrhoea—Mesalazine—Crohn's disease	0.000275	0.00179	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—IL23A—Crohn's disease	0.000273	0.0249	CbGpPWpGaD
Estropipate—Angiopathy—Prednisone—Crohn's disease	0.000272	0.00177	CcSEcCtD
Estropipate—ESR2—Ovarian Infertility Genes—SMAD3—Crohn's disease	0.000271	0.0247	CbGpPWpGaD
Estropipate—Immune system disorder—Prednisone—Crohn's disease	0.000271	0.00176	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.000268	0.0244	CbGpPWpGaD
Estropipate—Dizziness—Mesalazine—Crohn's disease	0.000266	0.00173	CcSEcCtD
Estropipate—Alopecia—Prednisone—Crohn's disease	0.000265	0.00173	CcSEcCtD
Estropipate—Mental disorder—Prednisone—Crohn's disease	0.000263	0.00171	CcSEcCtD
Estropipate—Nausea—Azathioprine—Crohn's disease	0.000262	0.00171	CcSEcCtD
Estropipate—Erythema—Prednisone—Crohn's disease	0.000261	0.0017	CcSEcCtD
Estropipate—Malnutrition—Prednisone—Crohn's disease	0.000261	0.0017	CcSEcCtD
Estropipate—Vomiting—Mesalazine—Crohn's disease	0.000256	0.00167	CcSEcCtD
Estropipate—Rash—Mesalazine—Crohn's disease	0.000254	0.00165	CcSEcCtD
Estropipate—Dermatitis—Mesalazine—Crohn's disease	0.000254	0.00165	CcSEcCtD
Estropipate—Headache—Mesalazine—Crohn's disease	0.000252	0.00164	CcSEcCtD
Estropipate—Nausea—Mesalazine—Crohn's disease	0.000239	0.00156	CcSEcCtD
Estropipate—Angioedema—Prednisone—Crohn's disease	0.000238	0.00155	CcSEcCtD
Estropipate—Vertigo—Prednisone—Crohn's disease	0.000234	0.00153	CcSEcCtD
Estropipate—Myalgia—Prednisone—Crohn's disease	0.000222	0.00145	CcSEcCtD
Estropipate—Arthralgia—Prednisone—Crohn's disease	0.000222	0.00145	CcSEcCtD
Estropipate—Anxiety—Prednisone—Crohn's disease	0.000221	0.00144	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000221	0.00144	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—Crohn's disease	0.000213	0.00139	CcSEcCtD
Estropipate—Oedema—Prednisone—Crohn's disease	0.000213	0.00139	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000212	0.0193	CbGpPWpGaD
Estropipate—Infection—Prednisone—Crohn's disease	0.000212	0.00138	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—Crohn's disease	0.000209	0.00136	CcSEcCtD
Estropipate—Skin disorder—Prednisone—Crohn's disease	0.000207	0.00135	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000194	0.00126	CcSEcCtD
Estropipate—Insomnia—Prednisone—Crohn's disease	0.000193	0.00125	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—Crohn's disease	0.000191	0.00125	CcSEcCtD
Estropipate—Dyspepsia—Prednisone—Crohn's disease	0.000187	0.00122	CcSEcCtD
Estropipate—ESR1—Nuclear signaling by ERBB4—RBX1—Crohn's disease	0.000186	0.0169	CbGpPWpGaD
Estropipate—Fatigue—Prednisone—Crohn's disease	0.000184	0.0012	CcSEcCtD
Estropipate—Constipation—Prednisone—Crohn's disease	0.000182	0.00119	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—HSPA1B—Crohn's disease	0.000175	0.016	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Prednisone—Crohn's disease	0.000174	0.00113	CcSEcCtD
Estropipate—Urticaria—Prednisone—Crohn's disease	0.000169	0.0011	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—Crohn's disease	0.000168	0.0011	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—Crohn's disease	0.000168	0.0011	CcSEcCtD
Estropipate—Hypersensitivity—Prednisone—Crohn's disease	0.000157	0.00102	CcSEcCtD
Estropipate—Asthenia—Prednisone—Crohn's disease	0.000153	0.000995	CcSEcCtD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000152	0.0138	CbGpPWpGaD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000152	0.0138	CbGpPWpGaD
Estropipate—Pruritus—Prednisone—Crohn's disease	0.000151	0.000981	CcSEcCtD
Estropipate—Diarrhoea—Prednisone—Crohn's disease	0.000146	0.000949	CcSEcCtD
Estropipate—Dizziness—Prednisone—Crohn's disease	0.000141	0.000917	CcSEcCtD
Estropipate—Vomiting—Prednisone—Crohn's disease	0.000135	0.000882	CcSEcCtD
Estropipate—Rash—Prednisone—Crohn's disease	0.000134	0.000875	CcSEcCtD
Estropipate—Dermatitis—Prednisone—Crohn's disease	0.000134	0.000874	CcSEcCtD
Estropipate—Headache—Prednisone—Crohn's disease	0.000133	0.000869	CcSEcCtD
Estropipate—ESR1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000128	0.0117	CbGpPWpGaD
Estropipate—Nausea—Prednisone—Crohn's disease	0.000126	0.000824	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00011	0.00998	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000107	0.00973	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000103	0.00937	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—GPX4—Crohn's disease	0.000101	0.00917	CbGpPWpGaD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	9.44e-05	0.0086	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	9.44e-05	0.00859	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	8.79e-05	0.00801	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—F5—Crohn's disease	8.74e-05	0.00796	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	8.58e-05	0.00781	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	8.33e-05	0.00758	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	8e-05	0.00729	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL10—Crohn's disease	7.93e-05	0.00722	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—MPO—Crohn's disease	7.68e-05	0.00699	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL10—Crohn's disease	7.59e-05	0.00691	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—SMAD3—Crohn's disease	7.48e-05	0.00681	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Crohn's disease	7.45e-05	0.00678	CbGpPWpGaD
Estropipate—ESR1—Nuclear signaling by ERBB4—JAK2—Crohn's disease	7.26e-05	0.00661	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PTRF—Crohn's disease	7.19e-05	0.00655	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	6.89e-05	0.00628	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	6.89e-05	0.00628	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	6.75e-05	0.00615	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	6.5e-05	0.00592	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—RBX1—Crohn's disease	6.26e-05	0.0057	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	6.13e-05	0.00559	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	6.1e-05	0.00556	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	5.99e-05	0.00545	CbGpPWpGaD
Estropipate—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	5.42e-05	0.00494	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—IFNG—Crohn's disease	5.12e-05	0.00466	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	4.96e-05	0.00452	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	4.94e-05	0.0045	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	4.85e-05	0.00442	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—CXCL8—Crohn's disease	4.76e-05	0.00433	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	4.61e-05	0.0042	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	4.61e-05	0.0042	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—IFNG—Crohn's disease	4.57e-05	0.00416	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	4.56e-05	0.00416	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—UBE2D1—Crohn's disease	4.51e-05	0.0041	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IFNG—Crohn's disease	4.46e-05	0.00406	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	4.33e-05	0.00395	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.33e-05	0.00394	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ZFP36L1—Crohn's disease	4.31e-05	0.00392	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—JAK2—Crohn's disease	4.3e-05	0.00392	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.29e-05	0.00391	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	4.16e-05	0.00379	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—CXCL8—Crohn's disease	4.15e-05	0.00378	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	4.04e-05	0.00368	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—CRP—Crohn's disease	4.04e-05	0.00368	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	3.88e-05	0.00353	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.8e-05	0.00346	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.78e-05	0.00344	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—IL1B—Crohn's disease	3.77e-05	0.00343	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—ICAM1—Crohn's disease	3.71e-05	0.00338	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—DNMT3A—Crohn's disease	3.66e-05	0.00334	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PTRF—Crohn's disease	3.63e-05	0.0033	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.5e-05	0.00319	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.5e-05	0.00319	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	3.47e-05	0.00316	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.25e-05	0.00296	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	3.23e-05	0.00294	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—SMAD3—Crohn's disease	3.22e-05	0.00294	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	3.21e-05	0.00292	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—STAT3—Crohn's disease	3.16e-05	0.00288	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	3.1e-05	0.00282	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.02e-05	0.00275	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.95e-05	0.00269	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.9e-05	0.00264	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.87e-05	0.00261	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IFNG—Crohn's disease	2.82e-05	0.00257	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.77e-05	0.00252	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—IL6—Crohn's disease	2.67e-05	0.00243	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	2.64e-05	0.0024	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.57e-05	0.00234	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—TYK2—Crohn's disease	2.56e-05	0.00233	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	2.53e-05	0.0023	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL1B—Crohn's disease	2.52e-05	0.00229	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	2.49e-05	0.00227	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—HSPA1B—Crohn's disease	2.47e-05	0.00225	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.47e-05	0.00225	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.46e-05	0.00224	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—JAK2—Crohn's disease	2.44e-05	0.00223	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.43e-05	0.00222	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.37e-05	0.00216	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.37e-05	0.00215	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	2.35e-05	0.00214	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.34e-05	0.00213	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.34e-05	0.00213	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL6—Crohn's disease	2.33e-05	0.00212	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	2.32e-05	0.00212	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.27e-05	0.00207	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	2.25e-05	0.00205	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	2.25e-05	0.00205	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	2.24e-05	0.00204	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.18e-05	0.00199	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ZFP36L1—Crohn's disease	2.17e-05	0.00198	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—UBE2D1—Crohn's disease	2.17e-05	0.00198	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.15e-05	0.00196	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ACKR2—Crohn's disease	2.06e-05	0.00188	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.03e-05	0.00185	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.02e-05	0.00184	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	2e-05	0.00182	CbGpPWpGaD
Estropipate—ALB—Hemostasis—F5—Crohn's disease	2e-05	0.00182	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MLN—Crohn's disease	1.95e-05	0.00178	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	1.93e-05	0.00176	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.92e-05	0.00175	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.92e-05	0.00175	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—DNMT3A—Crohn's disease	1.85e-05	0.00168	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TNF—Crohn's disease	1.83e-05	0.00166	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.81e-05	0.00165	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.8e-05	0.00164	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TAGAP—Crohn's disease	1.79e-05	0.00163	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.72e-05	0.00157	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.71e-05	0.00155	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.71e-05	0.00155	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.65e-05	0.0015	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—MTMR3—Crohn's disease	1.64e-05	0.00149	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.63e-05	0.00148	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—SMAD3—Crohn's disease	1.63e-05	0.00148	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.57e-05	0.00143	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RSPO3—Crohn's disease	1.56e-05	0.00142	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—SMAD3—Crohn's disease	1.55e-05	0.00141	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.55e-05	0.00141	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SEL1L—Crohn's disease	1.48e-05	0.00135	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL6—Crohn's disease	1.48e-05	0.00134	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.47e-05	0.00134	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.46e-05	0.00133	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.45e-05	0.00132	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCR9—Crohn's disease	1.35e-05	0.00123	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.34e-05	0.00122	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.29e-05	0.00118	CbGpPWpGaD
Estropipate—ALB—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.00118	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—FADS1—Crohn's disease	1.28e-05	0.00116	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GPR65—Crohn's disease	1.26e-05	0.00115	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.26e-05	0.00114	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—IL6—Crohn's disease	1.25e-05	0.00114	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—HSPA1B—Crohn's disease	1.25e-05	0.00114	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ITGA4—Crohn's disease	1.23e-05	0.00112	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL3—Crohn's disease	1.2e-05	0.00109	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GPX4—Crohn's disease	1.2e-05	0.00109	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	1.17e-05	0.00107	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RASGRP1—Crohn's disease	1.16e-05	0.00106	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GCKR—Crohn's disease	1.16e-05	0.00105	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTMR3—Crohn's disease	1.1e-05	0.000999	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.09e-05	0.000997	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—UBE2D1—Crohn's disease	1.09e-05	0.000996	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.06e-05	0.000962	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	9.02e-06	0.000822	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTMR3—Crohn's disease	8.98e-06	0.000818	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCR6—Crohn's disease	8.97e-06	0.000817	CbGpPWpGaD
Estropipate—ALB—Metabolism—FADS1—Crohn's disease	8.55e-06	0.000778	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2RA—Crohn's disease	8.39e-06	0.000764	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RBX1—Crohn's disease	8.11e-06	0.000739	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPX4—Crohn's disease	8e-06	0.000729	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTGER4—Crohn's disease	7.9e-06	0.000719	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.85e-06	0.000715	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SMAD3—Crohn's disease	7.83e-06	0.000713	CbGpPWpGaD
Estropipate—ALB—Metabolism—GCKR—Crohn's disease	7.73e-06	0.000704	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTMR3—Crohn's disease	7.67e-06	0.000699	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—UBE2D1—Crohn's disease	7.11e-06	0.000648	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—FADS1—Crohn's disease	7e-06	0.000637	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.96e-06	0.000634	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RIPK2—Crohn's disease	6.9e-06	0.000628	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL3—Crohn's disease	6.73e-06	0.000613	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPX4—Crohn's disease	6.55e-06	0.000597	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RASGRP1—Crohn's disease	6.5e-06	0.000592	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GCKR—Crohn's disease	6.33e-06	0.000576	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—FADS1—Crohn's disease	5.98e-06	0.000544	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.92e-06	0.000539	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SOCS1—Crohn's disease	5.89e-06	0.000537	CbGpPWpGaD
Estropipate—ALB—Hemostasis—JAK2—Crohn's disease	5.64e-06	0.000514	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPX4—Crohn's disease	5.6e-06	0.00051	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GCKR—Crohn's disease	5.41e-06	0.000492	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SMAD3—Crohn's disease	5.09e-06	0.000463	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.83e-06	0.00044	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2RA—Crohn's disease	4.71e-06	0.000429	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FADS1—Crohn's disease	4.61e-06	0.00042	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.52e-06	0.000412	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPX4—Crohn's disease	4.32e-06	0.000393	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GCKR—Crohn's disease	4.17e-06	0.00038	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.96e-06	0.00036	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.86e-06	0.000352	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—Crohn's disease	3.68e-06	0.000335	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.38e-06	0.000308	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TYK2—Crohn's disease	3.32e-06	0.000302	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—Crohn's disease	3.22e-06	0.000293	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JAK2—Crohn's disease	3.17e-06	0.000288	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—Crohn's disease	2.89e-06	0.000263	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—Crohn's disease	2.32e-06	0.000212	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—Crohn's disease	2.15e-06	0.000196	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—Crohn's disease	2.01e-06	0.000183	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.76e-06	0.00016	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—Crohn's disease	1.72e-06	0.000157	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—Crohn's disease	1.62e-06	0.000148	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.51e-06	0.000137	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—Crohn's disease	1.33e-06	0.000121	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.16e-06	0.000106	CbGpPWpGaD
